Cadence Pharmaceuticals competitors

Patrick McEnany is a Chairman/CEO at CATALYST PHARMACEUTICALS, INC..

A world-renowned physician and entrepreneur, Lindsay Rosenwald has served the medical profession for over 30 years. In that time, Lindsay Rosenwald has achieved success in a wide array of services including venture capital, direct investing, asset management and investment banking within the field of life sciences and biotechnology. Most notably, Lindsay Rosenwald has been a significant creator of development-stage biotechnology companies. Throughout his professional career, Lindsay Rosenwald has overseen the development of more than 100 licensed clinical-stage medicines. A number of these drugs have earned approval from the U.S. Food and Drug Administration and foreign countries. One medicine in particular was to treat acute promyelocytic leukemia, which has since cured several thousands of incurable patients in the past decade. Under the guidance of Lindsay Rosenwald, the medicine has marked a dramatic shift in how the disease will be treated in the future. Another cancer medicine formulated under the leadership of Lindsay Rosenwald is a prostate cancer drug called abiraterone acetate. The company led by Lindsay Rosenwald that developed this drug became the first of its kind to be acquired for around $1 billion after the completion of just a single phase 2 study when Johnson & Johnson took ownership of the company in a short-term merger. Other drugs approved during the career of Lindsay Rosenwald include drugs approved for treatment of diseases such as schizophrenia, influenza, fibromyalgia, infant respiratory distress syndrome, and obesity. After graduating from southeast Pennsylvania’s Abington Senior High School in 1973, Lindsay Rosenwald matriculated at Pennsylvania State University. There, Lindsay Rosenwald received a bachelor’s degree in finance and economics, graduating a member of Beta Gamma Sigma, an international honor society.

Seth Lederman is a Co-Founder at Vela Pharmaceuticals Inc, Managing Member at Targent Inc, and Associate Professor at Columbia University. He has worked as Chairman at Lederle Laboratories, Associate Professor at Columbia University Vagelos College of Physicians and Surgeons, and Chairman/Founder at Tonix Pharmaceuticals. Seth attended Princeton University and Columbia University.